Gastrointestinal Mechanics: While cannabinoids exhibit potent anti-inflammatory and visceral pain-modulating properties throughout the digestive tract, activation of cannabinoid type 1 (CB1) receptors in the enteric nervous system exerts a complex biphasic effect on esophageal physiology. Specifically, CB1 stimulation reduces basal resting tone in the lower esophageal sphincter (LES) and transiently increases LES relaxations, facilitating the retrograde flow of gastric acid into the esophagus. Furthermore, acute confounding variables—such as late-night cannabinoid-induced appetite stimulation (‘munchies’) heavy in high-fat or acidic foods, and the direct mechanical pharyngeal irritation of combusted smoke—significantly amplify GERD symptoms. For patients suffering from reflux, Dr. Benjamin Caplan recommends switching from combustion to sublingual tinctures, avoiding cannabinoid intake within 2 to 3 hours of reclining, and combining therapy with non-acidic dietary modifications.
#47
Clinical Context
Background information relevant to the evolving cannabis medicine landscape.
Clinicians should counsel patients with GERD or at risk for reflux disease that cannabis use may exacerbate symptoms through relaxation of the lower esophageal sphincter, potentially worsening disease progression and treatment outcomes. This finding is particularly relevant for patients considering cannabis for symptom management of other conditions, as the gastrointestinal risks may outweigh perceived benefits and complicate existing GERD treatment plans.
A recent study has identified an association between cannabis use and increased risk of gastroesophageal reflux disease (GERD), particularly in patients with concurrent substance use disorders. The research suggests that cannabis may compromise lower esophageal sphincter function or alter gastric motility through cannabinoid effects on the enteric nervous system, leading to increased acid reflux symptoms. These findings are relevant to clinicians prescribing cannabis for chronic conditions, as GERD represents both a common comorbidity and a potential adverse effect that should be monitored during treatment. Patients with preexisting reflux disease or those prone to substance use disorders may warrant careful risk-benefit assessment before initiating cannabis therapy. Clinicians should counsel patients about potential gastrointestinal symptoms and consider alternative therapeutic options or gastroprotective measures in susceptible populations.
“What we’re seeing in observational data is an association between cannabis use and GERD symptoms, but I want to be clear that correlation doesn’t establish causation here, and we haven’t yet isolated whether it’s the cannabis itself, frequency of use, method of consumption, or confounding lifestyle factors driving this relationship. Until we have controlled trials specifically examining cannabis and GERD mechanisms, I’m counseling patients with reflux disease to be cautious and monitor their symptoms if they use cannabis, rather than making definitive recommendations either way.”
💊 While this study highlights an association between cannabis use and gastroesophageal reflux disease, clinicians should recognize that the reported link may reflect confounding factors including concurrent smoking, alcohol use, or underlying gastrointestinal conditions rather than a direct pharmacologic effect of cannabis alone. The mechanism by which cannabis might increase GERD risk remains unclear, as cannabinoids have complex and sometimes contradictory effects on lower esophageal sphincter pressure depending on route of administration and individual metabolism. Patients with existing GERD who use cannabis should be counseled that smoking or vaping cannabis, like tobacco smoke, may relax the lower esophageal sphincter and worsen symptoms, whereas the effects of edibles are less well characterized. Given the prevalence of cannabis use in many populations, asking patients about their consumption patterns during GERD assessment may help identify a modifiable risk factor worth addressing alongside standard lifestyle and dietary interventions. Until
💬 Join the Conversation
Have a question about how this applies to your situation?
Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers?
Join the forum discussion →
Have thoughts on this? Share it:
Frequently Asked Questions: Cannabis & Acid Reflux (GERD)
Does cannabis cause GERD or acid reflux?
Cannabis has not been definitively proven to cause GERD, but observational studies show a clear statistical correlation. Cannabinoids activate CB1 receptors that relax the lower esophageal sphincter (LES), which can make acid reflux episodes more frequent or severe.
Why does smoking weed worsen heartburn?
Inhaling hot smoke irritates the mucosal lining of the pharynx and esophagus, diminishes salivary clearance, and causes transient negative thoracic pressure that pulls stomach contents upward. Switching to sublingual tinctures or vaporization eliminates combustion irritation.
Cannabinoids (especially CBD and CBG) modulate visceral sensitivity and decrease gut inflammation, offering perceived pain relief even while acid reflux occurs. This requires careful clinical management to ensure underlying mucosal irritation is properly healed.
Avoid eating high-fat, spicy, or heavy meals immediately after consuming cannabis, elevate the head of your bed by 6 inches, avoid lying down within 3 hours of dosing, and remain properly hydrated to maintain healthy salivary bicarbonate levels.
Get the next evidence review in your inbox
Plain-language summaries of the newest cannabis research, written by a physician. Free to read, and you can unsubscribe at any time.
Join the growing cannabis community. Free. One-click subscribe. Delivered by Substack.
